involving improper assembly or transfer of dolichol-linked glycans to proteins in the ER, or type II defects, resulting from incorrect modification of the protein-attached glycans in the Golgi. 5 The CDGs cause multi-system disease, have a wide range of clinical presentations, and manifest variable expressivity. 6 The pleiotropism of the CDGs can be partially attributed to the fact that~50% of human proteins are glycosylated and that some glycosylation events are tissue specific. 7 A peculiar observation of the CDGs is that very few individuals have homozygous mutations compared to compound heterozygous mutations. [8] [9] [10] [11] [12] [13] Combined with biochemical assays for residual enzyme activity and studies of animal models, this paucity of homozygous mutations has been interpreted to suggest that a genotype conveying residual catalytic activity is required for survival. 10, 12, [14] [15] [16] It has been proposed that homozygous mutations are either lethal (due to null alleles) or result in a subclinical phenotype (due to hypomorphic alleles), attributed to a wide tolerance of enzymatic activity as reported in unaffected individuals. 9, 16 Indeed, Helander et al. have
reported two siblings with subclinical presentation of homozygous MPI-CDG due to a variant also found in compound heterozygous MPI-CDG-affected individuals. 17 Another unexplained observation among the CDGs is that cultured skin fibroblasts derived from individuals with PMM2-CDG (OMIM: 212065) have high residual enzymatic activity. 9 To better understand factors contributing to the prolonged survival of individuals with CDGs, we studied two siblings diagnosed with MOGS-CDG (OMIM: 606056). In contrast to the previously reported individual who died at 74 days of age, 18 Figure 1A ). The accession numbers for these SNVs are dbSNP: rs753961807 (c.65C>A) and rs587777323 (c.370C>T) and ClinVar: SCV000256097 (c.329G>A).
The paternal mutations encode p.Ala22Glu and p.Arg110His, alterations of two conserved amino acids.
The maternal mutation encodes p.Gln124*. The paternally inherited single-nucleotide variants (SNVs) are predicted by in silico analysis to alter mRNA splicing and protein stability, respectively. The maternally inherited SNV is expected to trigger nonsense-mediated decay of the mRNA. At this time, unlike for PMM2 and MPI activity, there is no established method for measuring MOGS enzymatic activity, making it difficult to examine the enzymatic function of these mutations.
In light of these in silico predictions, we sought to better characterize the MOGS mRNA expressed in fibroblasts from individuals A and B. We amplified, cloned, and sequenced individual cDNA clones. This identified allelic combinations of SNVs absent in the parents (data not shown). To delineate the frequency and origin of these non-parental genotypes, we amplified and sequenced >100 clones of the region of genomic DNA encompassing the inherited SNVs (Table 1) . Approximately 60% of the clones for both individuals had recombinant, non-parental genotypes (Table 1 ); 7% and 13% had a wild-type genotype for individuals A and B, respectively. To determine whether non-parental genotypes also occurred in vivo, we analyzed R100 clones and >3,500 PacBio amplicons derived from the blood DNA of both MOGS-CDG-affected individuals. We found 6% and 18% non-parental genotypes for individual A and 19% and 13% non-parental genotypes for individual B ( Table 1) .
The observed genotypes suggest a rearrangement of genetic information during mitosis, which can be triggered by DNA double-strand breaks (DSBs) and subsequent homology-directed repair. 20 Mitotic recombination of chromosomes has been well characterized in model organisms and can result in either reciprocal or non-reciprocal transfer of genetic information between chromosomes. 21 In the case of reciprocal recombination, a chromosomal crossover event is resolved with no loss of genetic information; this is the mechanism underlying meiotic recombination. Non-reciprocal recombination results in the loss of genetic information, usually from the damaged allele during DSB repair. The result is a loss of heterozygosity at the repair locus such that both alleles carry the donor or template genotype, e.g., gene conversion. 20 Reciprocal recombination inherently requires crossing-over and the number of crossing-over events between chromatids will determine the amount of genetic material that is exchanged. A single cross-over event will result in a complete allelic switch between chromatids from the site of cross-over through the distal arm of the chromosome. Double cross-over events will limit the region of recombination to a shorter segment of the chromosome. 22 To test whether reciprocal or nonreciprocal mitotic recombination processes are responsible for the nonparental genotypes observed in cultured fibroblasts and blood from the MOGS-CDG-affected individuals, we used the RainDrop digital PCR system and custom TaqMan genotyping assays to test the frequency of the inherited SNVs (sequences in Table S1 ). By employing digital PCR, we were able to determine the genotype at the SNV of interest on thousands of individual alleles from fibroblast or blood DNA. This allowed for more accurate quantification of the reference and variant allele frequency versus the relative signal quantification that could be achieved using real-time PCR with these same genotyping assays. Analysis of the fibroblasts derived from individual A showed no significant loss of alleles in vitro (p > .9 by chi-square analysis). Likewise, analyses of blood-derived DNA showed no skewing in the frequency of the three SNVs for either MOGS-CDG-affected individual ( Figure 1C) , supporting a reciprocal mitotic intragenic recombination process as the origin of the non-parental genotypes in vivo.
Based on these observations, we proposed that mitotic intragenic recombination accounts for the reported paucity of homozygous versus compound heterozygous mutations associated with CDGs and is a mechanism for individual survival. Blood-derived DNA was unavailable, so we tested this using genomic DNA isolated from Single-allele cloning and sequencing reveals non-parental genotypes in genomic DNA from cultured fibroblasts of multiple CDG-affected individuals. Allele genotypes are shown in the first two columns; the reference alleles are indicated by an asterisk. Each row represents a single allele and the frequency of this allele. SNV accession numbers are provided in respective order for each variant. Figure S1 and FASTA sequences in Table S2 . The frequency of non-parental genotypes ranged from approximately 1.5% to 90%, with a strong correlation between the frequency of recombinant genotypes and the chromosomal distance between the variants (R 2 ¼ 0.97, Figure 2 ). In contrast, using Pacific Biosciences (PacBio) amplicon sequencing, recombination analysis of compound heterozygous SNVs at the GEN1 (OMIM: 612449) locus in cultured fibroblasts from an unaffected individual showed only 27% recombination across 800 nucleotides (Table 3; NIH Intramural Sequencing Center, primer sequences in Table S1 ). 23 This recombination frequency is well outside of the 95% prediction interval calculated from the CDG linear model (Figure 2 ). Digital PCR analysis of SNV frequency in the other CDG cell lines also detected evidence for both reciprocal and nonreciprocal mitotic recombination processes. We did not observe a decrease in SNV frequency among the PMM2-, ALG3-, ALG12-, or DPAGT1-CDG cell lines (Table 2 and Figures 3B-3G ), whereas we did observe a loss of both pathogenic SNVs for the ALG1-CDG cell line ( Figure 3G ) and loss of one reference SNV (MPI c.1205A) for the MPI-CDG cell line ( Figure 3C ). The loss of both pathogenic variants in the ALG1-CDG cell line suggests either nonreciprocal mitotic recombination generating two wild-type alleles or reciprocal mitotic recombination generating a wild-type allele and subsequent loss of heterozygosity. In total, these results provide evidence that increased rates of mitotic intragenic recombination, reciprocal and nonreciprocal, occur in CDG tissues and are a potential mechanism for survival and variability in individuals with CDGs.
The above observations suggest either that the mutations and genes involved in these CDGs reside at recombination hotspots or that there is selection of cells with increased levels of functional enzyme. The distribution of the studied genes around the genome and the absence of known recombination hotspots at those locations suggested to us that the studied CDG genes do not reside at recombination hotspots. Additionally, because the recombination frequency across these genes and samples had a linear correlation with distance between the heterozygous mutations, we concluded that it was more likely that the recombination rate across each of these genes was comparable rather than that each pair of mutations resided within intragenic recombination hotspots with comparable recombination rates. 24 These findings also suggest that, as has been observed for Bloom syndrome (OMIM: 210900) and WRN helicase (OMIM: 604611)-deficient cells, 25, 26 recombination and the consequent mosaicism contribute to the variable expressivity of CDGs along with the nature of the mutation. 9, 11, [25] [26] [27] attributed to mitotic intragenic recombination within somatic cells is further supported by residual enzymatic activity in CDG individual cells 8, 9 and the small number of reported homozygous mutations among the CDGs.
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Accession Numbers
The accession numbers for the previously unreported CDG variants studied in this paper are ClinVar: SCV000256094 (MPI; c.1205A>G), SCV000256095 (MPI; c.1253G>A), SCV000256096 (DPAGT1; c.584C>G), and SCV000256097 (c.329G>A).
Supplemental Data
Supplemental Data include one figure and two tables and can be found with this article online at http://dx.doi.org/10.1016/j. ajhg.2015.12.007. Sequence analysis via PacBio amplicon sequencing of single alleles in a healthy individual detects a low level of mitotic recombination in blood and fibroblasts. Allele genotypes are shown in the first two columns; the reference alleles are indicated by an asterisk. Each row represents a single allele and the frequency of this allele in the sequenced population. SNV accession numbers are provided in respective order for each variant.
